You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 641 Incidence and risk factors for stroke associated with immune checkpoint inhibitor therapy in cancer patients using real-world clinical data

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Immunotherapy toxicities
641 Incidence and risk factors for stroke associated with immune checkpoint inhibitor therapy in cancer patients using real-world clinical data

 

Online download statistics by month:

Online download statistics by month: November 2020 to September 2024

AbstractFullPdf
Nov 202077010
Dec 2020112021
Jan 20214405
Feb 20216203
Mar 202172015
Apr 202157011
May 202144010
Jun 20210010
Jul 20210019
Aug 2021006
Sep 20210011
Oct 202150023
Nov 202158020
Dec 202170015
Jan 202278013
Feb 20222803
Mar 20224604
Apr 2022152010
May 20228604
Jun 2022150012
Jul 20229002
Aug 202211009
Sep 202210809
Oct 202214205
Nov 2022110011
Dec 20229601
Jan 20237201
Feb 202313803
Mar 202312009
Apr 202311808
May 202314806
Jun 202313808
Jul 2023192016
Aug 202316009
Sep 202311805
Oct 202326009
Nov 202322009
Dec 202322206
Jan 20246404
Feb 20248002
Mar 202423406
Apr 202417409
May 202424008
Jun 202416909
Jul 2024234012
Aug 202421707
Sep 2024270013
Total54300421